New Study Shows PCR and FCR Have Significant Activity in B-cell Chronic Lymphocytic Leukemia
...ractory multiple myeloma
Jeffrey Mato...ezomib and Rituximab in relapsed and/or refractory waldenstrom
Macroblobulinemia; Long-term responses to Fludarabine and Rituximab in waldenstrom
More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
...nts with different underlying anemias will also be presented
RAD001 data demonstrating benefit in patients with relapsed and/or refractory waldenstrom
Macroglobulinemia (ASH Abstract #1011 ; Saturday, December 6, 2008; 5:30 - 7:30 PM PST)
More than 10 abstracts on p anobinostat ( L...
Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
... Tuesday, June 3, 2008, from 8:00am-12:00pm:
Abstract 8546: A Phase 2 trial of the novel oral Akt inhibitor
perifosine in relapsed and/or refractory waldenstrom
Investigators: Irene M. Ghobrial, X. Leleu, N. Rubin, R. Leduc, S.
Chuma, M. Nelson, P. G. Richardson, S. P. Treon, K. C. Anderson...